EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Combined Therapeutic Potential of Thymoquinone and Theaflavin Through P13k Pathway Suppression

Keerat Mann, Sangeetha S, Taniya Mary Martin, Meenakshi Sundaram Kishore Kumar

International Journal of Environmental Sciences · 01.09.2025 · 1201-1210

DOI: 10.64252/r2eq7f11 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Environmental Sciences, online erschienen am 01.09.2025. Verfasst von Keerat Mann und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The synergistic potential of natural phytochemicals in modulating key cancer related pathways offers a promising approach for therapeutic development. This study investigates the combined anti-cancer, anti-inflammatory, and antioxidant effects of Thymoquinone and theaflavin on KB cells.

Methods

Thymoquinone and theaflavin were evaluated individually and in combination (1:1,2:1,1:2) across a concentration range of 1 to 200 µg/mL. Cytotoxicity was assessed by MTT assay, anti-inflammatory activity was measured using Bovine serum albumin method, and antioxidant potential was determined via the DPPH radical scavenging assay. Gene expression analysis of P13K, Akt, mTOR, NF-kB, IL-6, Bcl-2 and BAX was performed using real-time PCR.

Results

Combination treatments, especially at a 1:1 ratio, demonstrated significantly enhanced cytotoxicity, superior inhibition of protein denaturation, and greater DPPH radical scavenging compared to individual compounds. Gene expression analysis revealed strong downregulation of the P13K/Akt/mTOR and NF-kB/IL-6 pathways and a shift toward apoptosis characterised by decreased Bcl-2 and increased BAX expression.

Conclusion

The synergistic interaction between Thymoquinone and theaflavin effectively modulates survival, inflammatory, and apoptotic pathways, offering a promising natural combination strategy for anticancer and anti-inflammatory therapies. Further preclinical investigations are warranted to validate their clinical applicability.

Zitieren

APA

Mann, K., S, S., Martin, T. M., & Kumar, M. S. K. (2025). Combined Therapeutic Potential of Thymoquinone and Theaflavin Through P13k Pathway Suppression. International Journal of Environmental Sciences, 1201-1210. https://doi.org/10.64252/r2eq7f11

Vancouver

Mann K, S S, Martin TM, Kumar MSK. Combined Therapeutic Potential of Thymoquinone and Theaflavin Through P13k Pathway Suppression. International Journal of Environmental Sciences. 2025:1201-1210. doi:10.64252/r2eq7f11

BibTeX
@article{Mann2025,
  author = {Mann, Keerat and S, Sangeetha and Martin, Taniya Mary and Kumar, Meenakshi Sundaram Kishore},
  title = {Combined Therapeutic Potential of Thymoquinone and Theaflavin Through P13k Pathway Suppression},
  journal = {International Journal of Environmental Sciences},
  year = {2025},
  pages = {1201--1210},
  doi = {10.64252/r2eq7f11}
}
Kostenlos starten →